Fidelity SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 9/19/2014 11:31:37 AM - Followers: 467 - Board type: Free - Posts Today: 54

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 

 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com
 


 
 


 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Annual Report (10-k) 09/15/2014 01:50:04 PM
CTIX News: Statement of Ownership (sc 13g) 09/04/2014 04:14:23 PM
CTIX News: Current Report Filing (8-k) 09/02/2014 06:29:26 AM
CTIX News: Cellceutix Anti-Fungal Compounds Awarded $1.5 Million SBIR Grant 06/23/2014 07:00:00 AM
CTIX News: Cellceutix Clinical Trial of Anti-Cancer Drug Kevetrin Entering Eighth Cohort 06/16/2014 07:00:00 AM
PostSubject
#69978  Sticky Note Cellceutix to President Obama: We Have The Tools CHM_760 09/19/14 07:22:18 AM
#69802  Sticky Note Why CTIX should break-above $2.47 to Blue Sky TOB 09/17/14 06:01:25 PM
#69616  Sticky Note Based on the stock movement, I think that BioHedge 09/16/14 06:47:44 PM
#69259  Sticky Note Update: Cellceutix's Antibiotic Brilacidin Should Move Share Price starbuxsux 09/15/14 12:46:54 AM
#67831  Sticky Note $CTIX News, SEC filings, FDA trials, misc., and KarinCA 09/03/14 06:13:02 PM
#57289  Sticky Note Cellceutix Initiates Clinical Trial of Prurisol as New starbuxsux 03/25/14 09:02:21 AM
#70025   Seen plenty of political cartoons here... Doesn't matter which MilesTeg 09/19/14 11:11:56 AM
#70022   Very Bold! Go Leo!! smitter 09/19/14 10:24:19 AM
#70021   L'audace, toujours l'audace! Tails 09/19/14 10:19:09 AM
#70020   Its good to be long CTIX and it BIzzy 09/19/14 10:17:50 AM
#70019   I believe you, cabel and App are correct. BooDog 09/19/14 10:07:10 AM
#70017   I am ready and waiting to add on corrections Rosterman 09/19/14 09:36:55 AM
#70016   Do you think there's any chance the blindfold Apparition 09/19/14 09:35:22 AM
#70015   Hi everyone! Just landed to find out the Looping 09/19/14 09:32:01 AM
#70014   Just know that he doesn't know any more cabel 09/19/14 09:29:28 AM
#70013   Hey Boo, DoubleJ23 09/19/14 09:25:39 AM
#70012   "Cellceutix believes positive data will position it perfectly rmzport 09/19/14 09:22:13 AM
#70011   Just know that he doesn't know any more BooDog 09/19/14 09:21:50 AM
#70010   Sept. 9 PR..."Cellceutix will not know the actual cabel 09/19/14 09:07:26 AM
#70009   Noretreat October is in the 4th Quarter!!!! iamactixaddict 09/19/14 09:05:53 AM
#70008   Also, look at the disclosure part of the DoubleJ23 09/19/14 09:03:56 AM
#70007   Maybe he said something else in the R&R TheDane 09/19/14 09:00:50 AM
#70006   At the same time,... it hints that the cabel 09/19/14 08:57:09 AM
#70005   Agreed. And you have to love the heart Apparition 09/19/14 08:53:12 AM
#70004   TD, I think Sept-Oct was stated to have come cabel 09/19/14 08:49:36 AM
#70003   just talked to one of my bio buddies BooDog 09/19/14 08:47:39 AM
#70002   It was an interesting tactical PR taking advantage TheDane 09/19/14 08:46:53 AM
#70001   RT, I wrote Leo and let him know Ovidius 09/19/14 08:41:30 AM
#70000   It would seem to me that they did cabel 09/19/14 08:39:50 AM
#69999   Yes that really is publicly staking the company's frrol 09/19/14 08:38:12 AM
#69998   It's possible the company is raising capital to I Need Help 09/19/14 08:36:56 AM
#69997   6 weeks to a flood of amazing data smitter 09/19/14 08:34:35 AM
#69996   Wow! Super Suh-Weetness News!!!! smitter 09/19/14 08:33:57 AM
#69995   I agree. The title says it all. Damn.... Apparition 09/19/14 08:33:16 AM
#69994   Leo has gone from Sheriff of Superbugs to Matagordaville 09/19/14 08:25:40 AM
#69993   The title is a heck of an assertion, frrol 09/19/14 08:20:43 AM
#69992   Nice job Leo! Maybe this will catch some John B 09/19/14 08:20:37 AM
#69991   I think in the 10-K there were a cabel 09/19/14 08:12:04 AM
#69990   I suggested to Leo that he fastrack the uplisting. cabel 09/19/14 08:10:21 AM
#69989   In earlier communication we heard 4th quarter and noretreat 09/19/14 08:08:15 AM
#69988   This PR will bring a fresh new set Ultimate01 09/19/14 08:05:58 AM
#69987   NEWS. Alright!!! Matagordaville 09/19/14 08:04:22 AM
#69986   Is there a difference bewteen UNBLINDING and Top-Line results,..? cabel 09/19/14 07:57:37 AM
#69985   I'd be surprised if $2.47 is not the Ovidius 09/19/14 07:53:56 AM
#69984   The End of the Superbug! noretreat 09/19/14 07:47:09 AM
#69983   Damn Leo!!! You Go Man!!! tombrady12nh 09/19/14 07:41:46 AM
#69982   This is as sensational PR As one can Amatuer17 09/19/14 07:35:01 AM
#69980   That is a BOLD statement, the opening line Vlady 1 09/19/14 07:23:44 AM
#69979   CHM_760 beat me to it. Wow, just BooDog 09/19/14 07:23:36 AM
#69978   Cellceutix to President Obama: We Have The Tools CHM_760 09/19/14 07:22:18 AM
#69977   100% return in shareprice once Brilacidin results are alexwv 09/19/14 06:40:27 AM
#69976   Smart money knows how to look behind the BooDog 09/19/14 06:07:48 AM
#69975   In my first communications with Leo back in Ovidius 09/19/14 01:08:41 AM
#69974   When valuing K I think we need to Tails 09/18/14 11:41:38 PM
#69973   Yes, I agree. That would be about as TOB 09/18/14 11:17:29 PM
#69972   I forgot about that one. I'll have to BigKahuna 09/18/14 10:49:41 PM
PostSubject